News tagged with combination therapy
SPACE, RF ablation combo safe and effective for lung cancer
(HealthDay)—For unresectable lung tumors, the combination of segmental pulmonary arterial chemoembolization (SPACE) and percutaneous radiofrequency (RF) ablation helps achieve better local tumor progression ...
Cancer
May 15, 2013 |
not rated yet |
0
Searching for therapeutic synergy in primary effusion lymphoma
Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised patients, such as those with ...
Cancer
May 01, 2013 |
not rated yet |
0
Epoxide hydrolase inhibition and Thiazolidinediones: A therapy for cardiometabolic syndrome
Scientists at the Medical College of Wisconsin and the University of California at Davis, led by Dr. John Imig and Dr. Bruce Hammock have determined the synergistic actions of inhibiting soluble epoxide hydrolase (sEH) with ...
Diseases, Conditions, Syndromes
Apr 23, 2013 |
not rated yet |
1
New therapy holds promise for aggressive breast cancers
Australian researchers have developed a new therapy to treat a common and aggressive form of breast cancer and stop the disease spreading, with a 100% success rate reported in mice.
Cancer
Apr 16, 2013 |
5 / 5 (1) |
0
Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology
Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.
Medications
Apr 11, 2013 |
not rated yet |
0
Possible predictive biomarker for patients who may respond to autophagy inhibitors
Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Biomarkers discovered that may help predict response to drugs targeting KRAS-mutated NSCLC
Scientists have identified biomarkers that may help predict whether patients with KRAS-mutated non-small cell lung cancer (NSCLC) will respond to concurrent treatment with an MEK inhibitor and a PI3 kinase inhibitor, a drug ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Combo therapy helps knock out fungal meningitis
(HealthDay)— A drug regimen containing two powerful antifungal medicines—amphotericin B and flucytosine—reduced the risk of dying from cryptococcal meningitis by 40 percent compared to treatment with ...
Diseases, Conditions, Syndromes
Apr 03, 2013 |
5 / 5 (1) |
1
|
Japanese P2 study shows potential of combined vaccine and steroid drug in castration resistant PCa
Multi-peptide vaccination therapy combined with the low-dose steroid drug dexamethasone shows promise in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients.
Cancer
Mar 15, 2013 |
not rated yet |
0
Combination therapy provides similar clinical benefit as single drug treatment in MS
People with multiple sclerosis (MS) who were treated with combination therapy did not see significant clinical benefit over those treated with single drug therapy, but combination therapy did reduce the development of new ...
Neuroscience
Mar 11, 2013 |
not rated yet |
0
Common MS drugs taken together do not reduce relapse risk
A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While ...
Neuroscience
Mar 11, 2013 |
not rated yet |
0
Major risks of dual and triple antithrombotic therapy in patients with newly diagnosed atrial fibrillation
According to Dr. Samy Suissa, Director of Clinical Epidemiology, Jewish General Hospital, and Professor of Epidemiology, McGill University in Montreal, Canada, "treating physicians need to consider the clinical effectiveness ...
Cardiology
Mar 05, 2013 |
not rated yet |
0
New study opens door to multipronged attack against skin common cancer
Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is ...
Cancer
Feb 27, 2013 |
5 / 5 (2) |
0
|
Face values: Ability to recognize emotions in others impaired by AIDS
People with HIV are less able to recognise facial emotion than non-infected people finds a study published in the launch edition of BioMed Central's open access journal BMC Psychology. Reduction in their ability to recogn ...
Psychology & Psychiatry
Feb 26, 2013 |
1 / 5 (1) |
0
Moxifloxacin monotherapy equivalent to antibiotic combo
(HealthDay)—Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer ...
Cancer
Jan 30, 2013 |
not rated yet |
0
Combination therapy
In contemporary usage, the expression combination therapy most often refers to the simultaneous administration of two or more medications to treat a single disease, but the expression is also used when other types of therapy are used at the same time.
Conditions treated with combination therapy include tuberculosis, leprosy, cancer, malaria, and HIV/AIDS.
Combination therapy may seem costlier than monotherapy in the short term but causes significant savings: lower treatment failure rate, lower case-fatality ratios, slower development of resistance and consequently, less money needed for the development of new drugs.
For more information about Combination therapy, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
